3D Decellularized Native Extracellular Matrix Scaffold for In Vitro Culture Expansion of Human Wharton's Jelly-Derived Mesenchymal Stem Cells (hWJ MSCs)
- PMID: 28963712
- DOI: 10.1007/7651_2017_71
3D Decellularized Native Extracellular Matrix Scaffold for In Vitro Culture Expansion of Human Wharton's Jelly-Derived Mesenchymal Stem Cells (hWJ MSCs)
Abstract
Mesenchymal stem cells (MSCs) are derived from Wharton's jelly tissue of the human umbilical cord. Given appropriate culture conditions, these cells can self-renew and differentiate into multiple cell types across the lineages. Among the properties exhibited by these cells, immunomodulation through secretion of trophic factors has been widely exploited in a broad spectrum of preclinical/clinical regenerative applications. Moreover, the extracellular matrix is found to play a major role apart from niche cells in determining stem cell fate including that of MSCs. Therefore, the currently employed technique of two-dimensional culture expansion can alter the inherent properties of naïve MSCs originally residing within the three-dimensional space. This limitation can be overcome to some extent by using native extracellular matrix scaffold culture system which mimics the in situ microenvironment. In this chapter, we have elucidated the protocol for the preparation of a native extracellular matrix scaffold by decellularization of the MSC sheet and thereof culture expansion and characterization of human Wharton's jelly-derived MSCs.
Keywords: Decellularization; Extracellular matrix; Mesenchymal stem cells; Scaffold; Stem cell niche; Wharton’s jelly.
Similar articles
-
Wharton's Jelly Matrix Decellularization for Tissue Engineering Applications.Methods Mol Biol. 2018;1577:25-33. doi: 10.1007/7651_2017_61. Methods Mol Biol. 2018. PMID: 28786033
-
Comparative evaluation of morphology and osteogenic behavior of human Wharton's jelly mesenchymal stem cells on 2D culture plate and 3D biomimetic scaffold.J Cell Physiol. 2019 Dec;234(12):23123-23134. doi: 10.1002/jcp.28876. Epub 2019 May 24. J Cell Physiol. 2019. PMID: 31127624
-
Osteogenic differentiation of Wharton's jelly-derived mesenchymal stem cells cultured on WJ-scaffold through conventional signalling mechanism.Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1032-S1042. doi: 10.1080/21691401.2018.1528981. Epub 2018 Nov 19. Artif Cells Nanomed Biotechnol. 2018. PMID: 30449193
-
Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.Biomed Mater Eng. 2015;25(1 Suppl):137-43. doi: 10.3233/BME-141232. Biomed Mater Eng. 2015. PMID: 25538064 Review.
-
Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.Stem Cell Rev Rep. 2017 Feb;13(1):35-49. doi: 10.1007/s12015-016-9702-4. Stem Cell Rev Rep. 2017. PMID: 27853939 Review.
Cited by
-
A low dose cell therapy system for treating osteoarthritis: In vivo study and in vitro mechanistic investigations.Bioact Mater. 2021 Jun 2;7:478-490. doi: 10.1016/j.bioactmat.2021.05.029. eCollection 2022 Jan. Bioact Mater. 2021. PMID: 34466747 Free PMC article.
-
Engineering biomimetic bone marrow niche with gene modified mesenchymal stromal cells for ex vivo culture of human hematopoietic stem and progenitor cells.Stem Cell Res Ther. 2025 Jul 1;16(1):335. doi: 10.1186/s13287-025-04474-4. Stem Cell Res Ther. 2025. PMID: 40598600 Free PMC article.
-
A silk fibroin/decellularized extract of Wharton's jelly hydrogel intended for cartilage tissue engineering.Prog Biomater. 2019 Mar;8(1):31-42. doi: 10.1007/s40204-019-0108-7. Epub 2019 Jan 31. Prog Biomater. 2019. PMID: 30706299 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources